Bath & Body Works (NYSE:BBWI) Hits New 1-Year Low - What's Next?

Key Points

• Bath & Body Works shares reached a new 52-week low of $24.93, closing at $25.11 after experiencing a trading volume of over 10.5 million shares.
• Despite the decline, analysts maintain a consensus rating of "Moderate Buy" with an average price target of $39.69.
• The company announced a quarterly dividend of $0.20 per share, representing an annualized dividend yield of 3.2%.

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report)'s share price reached a new 52-week low on Saturday . The stock traded as low as $24.93 and last traded at $25.11, with a volume of 10541740 shares changing hands. The stock had previously closed at $26.29.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on BBWI shares. Barclays raised their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an "equal weight" rating in a research report on Friday, August 29th. The Goldman Sachs Group decreased their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a research report on Friday, May 30th. Citigroup decreased their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research report on Tuesday, August 19th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research report on Monday, July 28th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $39.69.

Bath & Body Works Stock Up 1.9%

The stock has a market capitalization of $5.44 billion, a PE ratio of 7.83, a PEG ratio of 0.86 and a beta of 1.49. The firm's fifty day moving average price is $29.46 and its two-hundred day moving average price is $29.69.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion during the quarter, compared to analysts' expectations of $1.55 billion. During the same period in the prior year, the company earned $0.37 earnings per share. The firm's revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's dividend payout ratio is presently 23.74%.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio purchased a new position in shares of Bath & Body Works in the 4th quarter worth $2,920,000. American Trust purchased a new position in shares of Bath & Body Works in the 4th quarter worth $205,000. Shufro Rose & Co. LLC purchased a new position in shares of Bath & Body Works in the 4th quarter worth $343,000. Wealth Enhancement Advisory Services LLC grew its stake in shares of Bath & Body Works by 179.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 30,030 shares of the company's stock worth $1,164,000 after buying an additional 19,297 shares in the last quarter. Finally, 111 Capital purchased a new position in shares of Bath & Body Works in the 4th quarter worth $424,000. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.